Reuters -- Belgian biotech company Galapagos has signed a global development deal with Swiss drugmaker Roche (ROG.VX), and said it was in a research sweet spot that could see more deals signed this year.
Reuters -- Belgian biotech company Galapagos has signed a global development deal with Swiss drugmaker Roche (ROG.VX), and said it was in a research sweet spot that could see more deals signed this year.
